We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Kills 2 Patents On Horizon Pain Drug Vimovo

Law360 (May 15, 2019, 7:19 PM EDT) -- The Federal Circuit ruled Wednesday that two patents on Horizon Pharma's pain reliever Vimovo are invalid, backing generics makers and reversing a lower court decision that upheld the patents on a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.